BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 26, 2001
View Archived Issues
NCX-2111: a new NicOx NO-releasing compound for micturition disorders
Read More
Multicenter clinical trial of NMP22 BladderChek begins
Read More
FDA licenses first nucleic acid test systems for screening plasma donors
Read More
Pharmacokinetics and tolerability of multiple i.v. doses of daptomycin
Read More
Interactions of new drug for ADHD with other commonly used medications tested clinically
Read More
Data related to PK/PD of roxifiban discussed at ACCP meeting
Read More
CDP-840 attenuates increased TNF-alpha synthesis in healthy subjects
Read More
CAT antibody displays human eotaxin-neutralizing activity in vitro and in vivo
Read More
Vertex to focus on development of second-generation p38 MAP kinase inhibitors
Read More
H1 receptor antagonist with analgesic and antiinflammatory properties
Read More
Canadian authorities approve Gleevec following priority review
Read More
New drug for improving ED filed for approval in U.S., Mexico
Read More
Forbes' cholesterol-lowering pharmaceutical advances to clinical trials in Europe
Read More
Potential of Ono-4817 in osteoarthritis Rx discussed in Edinburgh
Read More
Superior efficacy demonstrated for SB-265610 compared to 5-ASA in experimental colitis model
Read More
Phase III multinational clinical trial of Surfaxin launched in IRDS
Read More
Supplemental development program announced for oral renin inhibitor aliskiren
Read More
COPD the third indication to be explored for ABX-IL-8
Read More
BLA filed by Cangene for antihepatitis B product
Read More
Duphar reports preparation and use of new dopamine D4 agonists
Read More
Bax inhibitors from ARS associated with improved neuronal survival
Read More
Substituted pyridines with the ability to control synaptic transmission
Read More
FibroGen describes new compounds for fibrotic disorders
Read More
Inhibitors of cyclin-dependent kinase identified at BMS
Read More
Recent patent covers new platelet ADP receptor antagonists synthesized at Cor
Read More
NDA for Vanlev to be refiled by Bristol-Myers Squibb
Read More